Aptevo Therapeutics Inc. (APVO) — 10-K Filings
All 10-K filings from Aptevo Therapeutics Inc.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (3)
-
Aptevo's Mipletamig Shows Strong Efficacy, Safety in Frontline AML Trial
— Mar 26, 2026 Risk: medium
Aptevo Therapeutics Inc. (APVO) is a clinical-stage biotechnology company focused on developing novel immunotherapy candidates for cancer, utilizing its proprie -
Aptevo Therapeutics Files 2024 Annual Report
— Feb 14, 2025 Risk: medium
Aptevo Therapeutics Inc. filed its 10-K for the fiscal year ending December 31, 2024. The company, located in Seattle, WA, operates in the Pharmaceutical Prepar -
Aptevo Therapeutics Inc. Files 2023 Annual Report on Form 10-K
— Mar 5, 2024 Risk: medium
Aptevo Therapeutics Inc. (APVO) filed a Annual Report (10-K) with the SEC on March 5, 2024. Aptevo Therapeutics Inc. filed its 2023 Form 10-K on March 5, 2024.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX